Literature DB >> 16584140

Evaluation of functional stability of quercetin as a raw material and in different topical formulations by its antilipoperoxidative activity.

Rúbia Casagrande1, Sandra R Georgetti, Waldiceu A Verri, José R Jabor, Antonio C Santos, Maria J V Fonseca.   

Abstract

The present study evaluates the antioxidant activity of the flavonol quercetin, and its functional stability as a raw material and when added in formulations. The iron-chelating activity was determined using the bathophenanthroline assay, and the functional stability was evaluated with the antilipoperoxidative assay. Raw material presented concentration-dependent antilipoperoxidative and iron-chelating activities. The initial antilipoperoxidative activity of the raw material, cream and gel-cream were 63%, 78%, and 69%, respectively. There was no detectable loss of activity during 182 days (6 months) of storage at all tested temperatures (4 degrees C, room temperature [RT], 37 degrees C, and 45 degrees C) for the raw material. Considering the method variability of 10%, activity loss greater than 10% for nonionic cream was detected after 126 days at 4 degrees C (20.1%), decreasing thereafter to 22.2% after 182 days. At 45 degrees C, the loss of activity started after 182 days (13.2%). For the anionic gel-cream, activity loss started after 84 days (28.4%, 45 degrees C), decreasing after 182 days to 40.3% at 45 degrees C. At 37 degrees C, activity loss was detected after 182 days (12%). In conclusion, the results suggest that the activity of quercetin depends on iron chelation, and its possible usefulness as a topical antioxidant to prevent oxidative stress-induced skin damage depends on maintaining its antilipoperoxidative activity stored at RT, which avoids special storage conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584140      PMCID: PMC2750709          DOI: 10.1208/pt070110

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  18 in total

1.  Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.

Authors:  C Freitas; R H Müller
Journal:  Eur J Pharm Biopharm       Date:  1999-03       Impact factor: 5.571

Review 2.  Solid lipid nanoparticles: production, characterization and applications.

Authors:  W Mehnert; K Mäder
Journal:  Adv Drug Deliv Rev       Date:  2001-04-25       Impact factor: 15.470

3.  Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration.

Authors:  S A Wissing; R H Müller
Journal:  J Control Release       Date:  2002-06-17       Impact factor: 9.776

4.  A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles.

Authors:  S A Wissing; R H Müller
Journal:  Int J Cosmet Sci       Date:  2001-08       Impact factor: 2.970

5.  In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel.

Authors:  D B Chen; T Z Yang; W L Lu; Q Zhang
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-11       Impact factor: 1.645

6.  Constituents of Essential Oil of Artemisia arborescens.

Authors:  T Sacco; C Frattini; C Bicchi
Journal:  Planta Med       Date:  1983-01       Impact factor: 3.352

7.  Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.

Authors:  Roberta Cavalli; M Rosa Gasco; Patrizia Chetoni; Susi Burgalassi; M Fabrizio Saettone
Journal:  Int J Pharm       Date:  2002-05-15       Impact factor: 5.875

8.  Liposomal incorporation of Artemisia arborescens L. essential oil and in vitro antiviral activity.

Authors:  Chiara Sinico; Alessandro De Logu; Francesco Lai; Donatella Valenti; Maria Manconi; Giuseppe Loy; Leonardo Bonsignore; Anna Maria Fadda
Journal:  Eur J Pharm Biopharm       Date:  2005-01       Impact factor: 5.571

9.  Studies on the cyclosporin A loaded stearic acid nanoparticles.

Authors:  Q Zhang; G Yie; Y Li; Q Yang; T Nagai
Journal:  Int J Pharm       Date:  2000-05-10       Impact factor: 5.875

10.  Solid lipid microparticle formulations of the pyrethroid gamma-cyhalothrin-incompatibility of the lipid and the pyrethroid and biological properties of the formulations.

Authors:  Henrik K Frederiksen; Henning G Kristensen; Morten Pedersen
Journal:  J Control Release       Date:  2003-01-17       Impact factor: 9.776

View more
  6 in total

1.  Elucidating raw material variability--importance of surface properties and functionality in pharmaceutical powders.

Authors:  Sai P Chamarthy; Rodolfo Pinal; M Teresa Carvajal
Journal:  AAPS PharmSciTech       Date:  2009-06-05       Impact factor: 3.246

2.  Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair.

Authors:  Jui-Ling Hsu; Pui-Kei Leong; Yunn-Fang Ho; Lih-Ching Hsu; Pin-Hsuan Lu; Ching-Shih Chen; Jih-Hwa Guh
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

3.  The evaluation of different treatment protocols for trauma-induced lung injury in rats.

Authors:  Hızır Ufuk Akdemir; Aygül Güzel; Celal Katı; Latif Duran; Hasan Alaçam; Ayhan Gacar; Tolga Güvenç; Naci Murat; Bülent Sişman
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

4.  Quercetin in lyotropic liquid crystalline formulations: physical, chemical and functional stability.

Authors:  Fabiana T M C Vicentini; Rúbia Casagrande; Waldiceu A Verri; Sandra R Georgetti; M Vitória L B Bentley; Maria J V Fonseca
Journal:  AAPS PharmSciTech       Date:  2008-05-03       Impact factor: 3.246

5.  Ficaria verna Huds. extracts and their β-cyclodextrin supramolecular systems.

Authors:  Nicoleta G Hădărugă
Journal:  Chem Cent J       Date:  2012-03-05       Impact factor: 4.215

6.  The Effects of Hesperidin and Quercetin on Serum Tumor Necrosis Factor-Alpha and Interleukin-6 Levels in Streptozotocin-induced Diabetes Model.

Authors:  Eda Dokumacioglu; Hatice Iskender; Tugba Mazlum Sen; Imran Ince; Ali Dokumacioglu; Yalcin Kanbay; Elif Erbas; Sinan Saral
Journal:  Pharmacogn Mag       Date:  2018-04-10       Impact factor: 1.085

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.